Amgen director receives 665-share equity grant
MILES AMY E reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MILES AMY E reported acquisition or exercise transactions in this Form 4 filing.
Amgen Inc. director Amy E. Miles received an equity award of 665 shares of common stock as a grant under the company’s director incentive program. The award, structured as Restricted Stock Units that vested immediately and settle one-for-one in common shares, increased her direct holdings to 5,640 shares. This total includes 408 dividend equivalents credited to her unvested RSUs under a qualifying dividend reinvestment plan.
Insider Trade Summary
Grant/Award: 665 shares
Grant/Award
1 txn
Insider
MILES AMY E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 665 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 5,640 shares (Direct)
Footnotes (2)
- F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
- F2. These shares include 408 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
RSU grant size: 665 shares
Grant price: $0.00 per share
Total shares after grant: 5,640 shares
+1 more
4 metrics
RSU grant size
665 shares
Restricted Stock Units granted to director on 2026-05-19
Grant price
$0.00 per share
Equity award under director incentive program
Total shares after grant
5,640 shares
Direct Amgen common stock holdings following transaction
Dividend equivalents included
408 DEs
DEs credited to unvested RSUs and included in total holdings
Key Terms
Restricted Stock Units (RSUs), Director Incentive Program, dividend reinvestment plan, Dividend Equivalents (DEs)
4 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Director Incentive Program financial
"granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended"
dividend reinvestment plan financial
"subject to a qualifying dividend reinvestment plan"
A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.
Dividend Equivalents (DEs) financial
"These shares include 408 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amgen (AMGN) director Amy E. Miles report on this Form 4?
Amy E. Miles reported receiving a grant of 665 Restricted Stock Units that vest immediately and are paid in Amgen common stock. This equity award was made under Amgen’s director incentive program and increases her overall direct share ownership in the company.
Was Amy E. Miles’ Amgen (AMGN) equity award an open-market purchase or a compensation grant?
The transaction is a compensation grant, not an open-market purchase. The 665 shares were awarded at a price of $0.00 per share as Restricted Stock Units under Amgen’s 2009 Director Incentive Program, rather than being bought on the stock market.
What are the key terms of the Amgen (AMGN) RSUs granted to Amy E. Miles?
The Restricted Stock Units vest immediately and are paid one-for-one in Amgen common stock. Directors may defer payment under a chosen schedule. Related dividend equivalent units are credited to unvested RSUs and paid in shares along with cash for any remaining fractional amounts.
What are dividend equivalents (DEs) in Amy E. Miles’ Amgen (AMGN) holdings?
Dividend equivalents are units credited to her unvested RSUs under a dividend reinvestment plan. For Amy E. Miles, 408 DEs are included in her reported 5,640 shares and will be paid in Amgen common stock as the underlying RSUs vest, plus cash for fractional shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
